Changes in the expression of numerous genes (CDKN1A, SMAD3, MLH1 and PIK3IP1) caused by mutations in ARID1A contribute to the development of cancer and have been linked to the PI3K/AKT pathway in cell translocation,20 which was highly likely to become a therapeutic target for OC.21 This evidence concerns the gene SMAD3 and cancer.